Approximately 1,450 new cases and 430

deaths from cervical cancer were estimated to occur among Canadian women during 2000, resulting in an estimated incidence rate of 8.4 per 100,000 women.1 Observed declines in cervical cancer incidence and mortality rates in previous years are largely attributed to the widespread adoption of Pap screening.1 Current Canadian guide-lines recommend women receive annual Pap tests once sexually active or at age 18 with a reduction in screening frequency to every three years after two normal smears to the age of 69, in the presence of an organized screening program.2,3 Currently, there are no comprehensive screening pro